CK Cell Technologies Pty Ltd


CK Cell Technologies Pty Ltd

Accreditation No.


Site No.


Date of Accreditation

04 Aug 2021


Unit 31, 11 - 13 Brookhollow Avenue
Baulkham Hills, NSW 2153


Dr Kuldip Sidhu P: +61 0401766055


Services available to external clients

Scope of Accreditation

CK Cell Technologies Pty Ltd

ISO/IEC 17025 (2017)

Healthcare, Pharmaceutical and Media Products

Service Product Determinant Technique
Analysis in support of research Conditioned media; Exosomes and other cell-free products derived from stem cells; Human embryonic stem cells (hESC); Induced pluripotent stem cells (iPSC); Mesenchymal stem cells (MSC); Reprogrammed induced pluripotent stem cells (iPSC) Characterisation of stem cell based diagnostic and therapeutic products; Differentiation of stem cells; Identification of cytokines; Identification of growth factor; Protein identification; Quantification of proteins; RNA gene expression Bicinchoninic acid (BCA) protein assay; Cytokine array; Exosome extraction; Flow cytometry; Polymerase chain reaction (PCR); Trilineage differentiation, staining and quantification
Human adipose tissue; Human dental tissue; Whole blood Impacts of stem cell based diagnostic and therapeutic products on neurodegenerative disorders, osteoarthritis, skin regeneration and repair, spinal cord injury, diabetic foot ulcer, wound healing and acute respiratory distress syndrome Isolation of peripheral blood mononuclear cells (PBMC); Isolation, propagation and cryopreservation of stem cells; Lyophilisation; Preparation of conditioned media; Reprogramming of peripheral blood mononuclear cells (PBMC) to Induced pluripotent stem cells (iPSC)

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.